#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA636745	B	Change in calcium-induced activation of canine cardiac myofibrillar ATPase at 200 uM	Canis lupus familiaris	12	ALA1126243	single protein format	Scientific Literature
2.	ALA657718	F	Effective dose required to produce an increase in dP/dt5 by 1500 mmHg/s in cats	Felis catus	27	ALA1124518	organism-based format	Scientific Literature
3.	ALA657720	F	Effective dose required to produce an increase in dP/dt50, blood pressure by 1500 mmHg/s was determined in cat by intravenous administration	Felis catus	14	ALA1123792	organism-based format	Scientific Literature
4.	ALA659854	F	Maximum increase in dP/dt recorded in mmHg/s at the dose 0.3 mg/kg administered intravenously in cat	Felis catus	4	ALA1123792	organism-based format	Scientific Literature
5.	ALA659934	F	Maximum increase in dP/dt when administered intravenously in cats at 0.3 mg/kg dose.	Felis catus	6	ALA1124518	organism-based format	Scientific Literature
6.	ALA663075	F	Amount of time during which increase in administered orally in conscious dogs at 1 mg/kg	Canis lupus familiaris	13	ALA1124518	organism-based format	Scientific Literature
7.	ALA663914	F	Effective dose required to produce an increase in dP/dt5 by 1500 mmHg/s in dogs	Canis lupus familiaris	14	ALA1124518	organism-based format	Scientific Literature
8.	ALA663916	F	Effective dose required to produce an increase in dP/dt50, blood pressure by 1500 mmHg/s was determined in dog by intravenous administration	Canis lupus familiaris	11	ALA1123792	organism-based format	Scientific Literature
9.	ALA666846	F	Maximum increase in dP/dt recorded in mmHg/s at the dose 1.0 mg/kg administered intravenously in dog	Canis lupus familiaris	5	ALA1123792	organism-based format	Scientific Literature
10.	ALA663679	F	Maximum increase in dP/dt when administered intravenously in dogs at 1 mg/kg dose.	Canis lupus familiaris	6	ALA1124518	organism-based format	Scientific Literature
11.	ALA665418	F	Maximum increase in dP/dt60 when administered orally in dogs at dose 1 mg/kg.	Canis lupus familiaris	5	ALA1124518	organism-based format	Scientific Literature
12.	ALA672467	F	Time after which maximum increase in contractility was observed when administered orally in conscious dogs at 1 mg/kg	Canis lupus familiaris	11	ALA1124518	organism-based format	Scientific Literature
13.	ALA781859	F	Effective dose required to produce an increase in dP/dt5 by 1500 mmHg/s in rats	Rattus norvegicus	55	ALA1124518	organism-based format	Scientific Literature
14.	ALA781861	F	Effective dose required to produce an increase in dP/dt50, blood pressure by 1500 mmHg/s was determined in rat by intravenous administration	Rattus norvegicus	25	ALA1123792	organism-based format	Scientific Literature
15.	ALA789298	F	Maximum increase in dP/dt recorded in mmHg/s at the dose 0.1 mg/kg administered intravenously in rat.	Rattus norvegicus	1	ALA1123792	organism-based format	Scientific Literature
16.	ALA793515	F	Maximum increase in dP/dt when administered intravenously in rats at 0.1 mg/kg dose.	Rattus norvegicus	2	ALA1124518	organism-based format	Scientific Literature
17.	ALA819314	B	Inhibition of dog left ventricle sarcoplasmic reticulum bound low-Km c-AMP phosphodiesterase	Canis lupus familiaris	14	ALA1126243	protein format	Scientific Literature
18.	ALA4651403	F	Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging	Chlorocebus sabaeus	4,309	ALA4651402	organism-based format	IMI-CARE SARS-CoV-2 Data